LISI Group sales up for H1 11 September 2024

LISI Group achieved sales of €903.6 million in the first half of 2024, up 10% compared to 2023, with LISI AEROSPACE up 21.8% compared to the same period of last year, and LISI AUTOMOTIVE and LISI MEDICAL finishing down 2.5% and 0.8% respectively.

LISI AEROSPACE sales totalled €505 million at the end of the first half of the year. The ‘Fasteners’ segment grew in Europe by 26.2% and 22.9% in the United States on an already high comparison basis in H1 2023. As well as this, the ‘Structural Components’ segment grew by 17.1%.

The good long-term outlook for the global commercial flight of the aeronautical market is reflected in high order levels among manufacturers. The increases in monthly production rates for single aisle aircraft were revised downwards at the end of the half year with no impact on the division. The significant return of long haul orders, as well as the good performance of the helicopter and military market segments, are also supporting demand over the long-term.

LISI AUTOMOTIVE’s sales amounted to €310.6 million. Order intake for new products remains at the high-level of 13.6% of sales over the half year (14.2% in 2023) which equates to €42 million (€45.2 million in 2023). The LISI AUTOMOTIVE division thus confirms its positioning in electromobility and its ability to quickly adapt its product ranges. These performance results also testify to its increased diversification with Chinese or American OEMs and manufacturers, for braking systems or interior fittings.

The LISI AUTOMOTIVE division is expected to experience a slowdown in demand from its main customers during the second half of the year in a market experiencing profound technological and geographic changes. Added to this is strong pressure on prices across the entire automotive industry with the will to lower the manufacturing costs of electric vehicles. The LISI AUTOMOTIVE division will therefore have to continue to demonstrate discipline and adaptation while ensuring the development and ramp-up of new products resulting from record order intake in recent years.

LISI MEDICAL’s sales amounted to €88.5 million in H1 2024. In addition to this unfavourable comparison basis in the first quarter was a movement to adjust the inventory levels of the division’s main customers and production disrupted by difficulties in sourcing raw materials.  

Editor

Claire Aldridge Editor t: +44 (0) 1727 743 889

Biog

Having spent a decade in the fastener industry experiencing every facet – from steel mills, fastener manufacturers, wholesalers, distributors, as well as machinery builders and plating + coating companies, Claire has developed an in-depth knowledge of all things fasteners.

Alongside visiting numerous companies, exhibitions and conferences around the world, Claire has also interviewed high profile figures – focusing on key topics impacting the sector and making sure readers stay up to date with the latest developments within the industry.